Abstract:We present a practical guide for analyzing the genetic aspects of lymphoblastic leukaemia/lymphoma according to the 5th edition of the World Health Organization (WHO) classification of haematolymphoid neoplasms (WHO-HAEM5) issued in 2024. The WHO-HAEM5 acknowledges the increasing importance of genetics in the diagnosis of lymphoid neoplasia. Classification is based on the established genetic subtypes according to cell lineage, with precursor cell neoplasms followed by mature malignancies. This guide describes those genetic abnormalities in acute precursor B- and T-cell neoplasms required for risk stratification, and for treatment, providing diagnostic algorithms under the headings of 'essential' and 'desirable' diagnostic criteria.

What problem does this paper attempt to address?

This paper aims to provide a practical guide for analyzing the genetic aspects of lymphoblastic leukemia/lymphoma according to the 5th edition of the World Health Organization (WHO) Classification of Tumours of Haematopoietic and Lymphoid Tissues (WHO - HAEM5) published in 2024. The paper emphasizes the increasing importance of genetics in the diagnosis of lymphocytic tumors and classifies them based on established genetic subtypes, which are divided into precursor cell tumors and mature malignancies according to cell lineages. Specifically, the paper describes the genetic abnormalities used for risk stratification and treatment in acute precursor B - cell and T - cell tumors and provides diagnostic algorithms, including "required" and "desired" diagnostic criteria. This helps clinicians more accurately identify patients' genetic characteristics, thereby formulating more effective treatment regimens. ### Main issues 1. **The role of genetics in diagnosis**: The paper emphasizes the importance of genetics in the diagnosis of lymphoblastic leukemia/lymphoma, especially in risk stratification and treatment decision - making. 2. **New genetic subtypes**: The paper introduces new genetic subtypes defined in B - ALL/LBL, while the classification of T - ALL/LBL is still mainly based on immunophenotype and histology. 3. **Diagnostic criteria**: The paper proposes "required" and "desired" diagnostic criteria for B - ALL/LBL and T - ALL/LBL to improve the accuracy and consistency of diagnosis. ### Key content - **Genetic subtypes of B - ALL/LBL**: - High Hyperdiploidy (HHD) - Hypodiploidy - Intrachromosomal rearrangement of chromosome 21 (iAMP21) - BCR::ABL1 fusion - KMT2A rearrangement - ETV6::RUNX1 fusion - TCF3::PBX1 fusion - IGH::IL3 fusion - TCF3::HLF fusion - Other well - defined genetic abnormalities - **Classification of T - ALL/LBL**: - Based on immunophenotype and histology - Early T - precursor lymphoblastic leukemia/lymphoma (ETP - ALL/LBL) ### Diagnostic techniques - **Cytogenetic testing**: such as karyotype analysis and fluorescence in situ hybridization (FISH) - **High - throughput sequencing**: such as whole - genome sequencing (WGS), single - nucleotide polymorphism arrays (SNP arrays), RNA sequencing - **Optical Genome Mapping (OGM)** ### Conclusion By providing detailed genetic subtypes and diagnostic criteria, the paper aims to help clinicians more accurately diagnose and treat lymphoblastic leukemia/lymphoma. With the continuous development and integration of new genetic methods, future classifications will be further refined.

Genetic alterations in lymphoblastic leukaemia / lymphoma – a practical guide to WHO HAEM5

Genetic alterations in chronic lymphocytic leukemia and plasma cell neoplasms – a practical guide to WHO HAEM5

Genetic studies in clonal haematopoiesis, myelodysplastic neoplasms and acute myeloid leukaemia – a practical guide to WHO-HAEM5

Genetic alterations in mature B- and T-cell lymphomas – a practical guide to WHO-HAEM5

Overview on WHO-HAEM5 and the diagnostic relevance of genetic alterations for the classification

Genetic alterations in myeloproliferative and myelodysplastic/myeloproliferative neoplasms – a practical guide to WHO-HAEM5

The 5th edition of the World Health Organization Classification of mature lymphoid and stromal tumors – an overview and update

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

Hairy cell leukemia variant and WHO classification correspondence Re: 5 th edition WHO classification haematolymphoid tumors: lymphoid neoplasms

What is new in the 5th edition of the World Health Organization classification of mature B and T/NK cell tumors and stromal neoplasms?

Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms—Updated Classification and New Concepts

The fifth edition of the WHO classification of mature B‐cell neoplasms: open questions for research

Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms

The 5th Edition of the World Health Organization (WHO) Classification of Hematolymphoid Tumors: What's New in Pediatrics?

The fifth edition of the WHO-Classification - what is new for cutaneous lymphomas?

Advances towards genome‐based acute myeloid leukemia classification: A comparative analysis of WHO‐HAEM4R, WHO‐HAEM5, and International Consensus Classification

A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas

Classifications of cutaneous lymphomas and lymphoproliferative disorders: An update from the EORTC cutaneous lymphoma histopathology group

NGS panel enhance precise diagnosis of myeloid neoplasms under WHO-HAEM5 and International Consensus Classification: An observational study

Lymphoma classification update: B-cell non-Hodgkin lymphomas